NCT04453397No Longer Available不适用
A Single Patient Protocol for TNB-383B, a Bispecific Antibody Targeting BCMA in a Subject With Relapsed/Refractory Multiple Myeloma
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- No Longer Available
- 试验地点
- 1
研究概览
简要总结
This is a single patient protocol for TNB-383B in a subject with relapsed/refractory multiple myeloma (MM) who is not a candidate for treatment regimens known to provide clinical benefit in MM.
研究设计
- 研究类型
- Expanded Access
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adequate bone marrow function
- •eGFR ≥ 30 mL/min
- •Total bilirubin ≤ 1.5 × upper limit of normal (ULN)
- •Serum calcium (corrected for albumin) at or below the ULN range
排除标准
- •Candidate for treatment regimens known to provide clinical benefit in MM
- •Active infection requiring parenteral anti-infective treatment
- •Any medical or psychiatric condition which in the opinion of the investigator or Teneobio Medical Monitor places the subject at an unacceptably high risk for toxicities, could interfere with successful or safe delivery of therapy, or could interfere with evaluation of the investigational product or interpretation of subject safety
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
2 期
A Study of TQ-B3101 in Subjects With Relapsed or Refractory Anaplastic Large Cell Lymphoma (ALCL)Relapsed/Refractory Anaplastic Large Cell Lymphoma (ALCL)NCT04306887Chia Tai Tianqing Pharmaceutical Group Co., Ltd.30
Unknown
2 期
A Study of TQ-B3525 in the Treatment of Relapsed / Refractory Follicular Lymphoma (FL)Relapsed / Refractory Follicular LymphomaNCT04324879Chia Tai Tianqing Pharmaceutical Group Co., Ltd.80
Available
不适用
A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate CancerProstate CancerNCT04337099Matrix Biomed, Inc.
已完成
不适用
To compare the polyurethane foam dressing (hydrocellular) and the hydrocolloid dressing in patients with Pressure Ulcers (stage II) in primary careStage II pressure ulcer (ulcer with epithelialisation tissue)Skin and Connective Tissue DiseasesStage II decubitus ulcer and pressure areaISRCTN57842461Primary Health Service of the Balearic Islands (Spain)820
Unknown
2 期
A Study of TQ-B3525 Tablet in the Treatment of Relapsed / Refractory Mantle Cell Lymphoma (MCL)Relapsed / Refractory Mantle Cell Lymphoma (MCL)NCT04398953Chia Tai Tianqing Pharmaceutical Group Co., Ltd.102